To sum up, AKIP1 promotes cell invasion and stemness via activating HIF-1α and β-catenin pathways in gastric cancer under hypoxia, which indicates that AKIP1 may have the potential to serve as a therapeutic target in gastric cancer. This evidence concerns the gene HIF1A and gastric cancer.